Aptinyx Stock

Aptinyx ROA 2024

Aptinyx ROA

-0.97

Ticker

APTX

ISIN

US03836N1037

WKN

A2JPB1

In 2024, Aptinyx's return on assets (ROA) was -0.97, a 49.17% increase from the -0.65 ROA in the previous year.

Aptinyx Aktienanalyse

What does Aptinyx do?

Aptinyx Inc is a biopharmaceutical company specializing in the development of therapies for the treatment of neurological diseases. The company was founded in 2015 in Evanston, Illinois, USA, and has since achieved an impressive track record in researching and developing innovative therapies. The history of Aptinyx Inc begins with a group of experienced scientists and researchers who came together to push the boundaries of neuroscience research and discover new treatment options for people with brain disorders. The company is based on the belief that the human brain is a fascinating and complex entity that still holds many secrets. The company is committed to improving human well-being through innovative neurotherapeutic products and services. Aptinyx Inc's business model focuses on the research, development, and commercialization of novel therapeutic treatments for neurological diseases. The company closely collaborates with leading academic institutions and facilities to leverage the best research findings and methods. The company has a strong scientific foundation led by an experienced team of researchers and developers working on innovative biomarker and therapy strategies. Aptinyx Inc has focused on the development of neuromodulators and neuroprotectants to treat neurological diseases, including pain disorders, peripheral neuropathies, neuropathic pain, Parkinson's disease, post-traumatic stress disorder (PTSD), and other central nervous system disorders. Aptinyx Inc's products are based on a comprehensive understanding of the fundamentals of the nervous system and how it functions. The company offers a variety of products and services, including novel therapeutics for the treatment of pain, neuropathy, and other neurological diseases. These products are based on the utilization of Aptinyx's proprietary technologies to selectively modulate specific cell types and signaling pathways in the nervous system. The products and services of Aptinyx Inc have been regulated by leading health authorities in the US and Europe. Aptinyx Inc has two main divisions of products: the first focus is on the development of neuromodulators that specifically alleviate pain and modulate the brain. The second focus is on the development of neuroprotectants that help protect neurons and reduce inflammation in the nervous system. These two divisions are closely interconnected as they are based on a common platform grounded in the exploration of novel biomarkers and therapeutic targets. The products of Aptinyx Inc are designed for both pain relief and improvement of neural functions. Additionally, these products aim to enhance patient experience and quality of life. The company consistently collaborates with potential partners and experts to develop products tailored to the needs of patients and healthcare providers. Overall, Aptinyx Inc has revolutionized the world of neuroscience by exploring and developing innovative solutions for neurological diseases. The company has achieved an impressive track record by utilizing its scientific expertise and groundbreaking technologies to set new trends in neuroscience research and therapeutics. In summary, Aptinyx Inc has developed a unique approach to the development of neuromodulators and neuroprotectants based on a deep understanding of the structure and function of the nervous system. The products and services of the company have the potential to play a significant role in improving the quality of life for patients with neurological diseases. Aptinyx ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Aptinyx's Return on Assets (ROA)

Aptinyx's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Aptinyx's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Aptinyx's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Aptinyx’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Aptinyx stock

What is the Return on Assets (ROA) of Aptinyx this year?

The Return on Assets (ROA) of Aptinyx is -0.97 undefined this year.

What was the ROA of Aptinyx compared to the previous year?

The ROA of Aptinyx has increased by 49.17% compared to the previous year.

What consequences do high ROA have for investors of Aptinyx?

A high ROA is advantageous for investors of Aptinyx, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Aptinyx?

A low ROA can be unfavorable for investors of Aptinyx as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Aptinyx affect the company?

An increase in ROA of Aptinyx can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Aptinyx impact the company?

A reduction in the ROA of Aptinyx can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Aptinyx?

Some factors that can influence the ROA of Aptinyx include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Aptinyx important for investors?

The ROA of Aptinyx is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Aptinyx take to improve ROA?

To improve ROA, Aptinyx can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Aptinyx pay?

Over the past 12 months, Aptinyx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aptinyx is expected to pay a dividend of 0 USD.

What is the dividend yield of Aptinyx?

The current dividend yield of Aptinyx is .

When does Aptinyx pay dividends?

Aptinyx pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aptinyx?

Aptinyx paid dividends every year for the past 0 years.

What is the dividend of Aptinyx?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aptinyx located?

Aptinyx is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aptinyx kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aptinyx from 12/29/2023 amounting to 0.099 USD, you needed to have the stock in your portfolio before the ex-date on 1/2/2024.

When did Aptinyx pay the last dividend?

The last dividend was paid out on 12/29/2023.

What was the dividend of Aptinyx in the year 2023?

In the year 2023, Aptinyx distributed 0 USD as dividends.

In which currency does Aptinyx pay out the dividend?

The dividends of Aptinyx are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aptinyx

Our stock analysis for Aptinyx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aptinyx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.